# Polarized Reflectance Spectroscopy for Oral Lesions

> **NCT01604759** · PHASE1 · COMPLETED · sponsor: **British Columbia Cancer Agency** · enrollment: 40 (actual)

## Conditions studied

- Oral Cancer

## Interventions

- **DEVICE:** Polarized Reflectance Spectroscopy System

## Key facts

- **NCT ID:** NCT01604759
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-01-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01604759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01604759, "Polarized Reflectance Spectroscopy for Oral Lesions". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT01604759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*